Literature DB >> 26514521

Shikonin Induced Necroptosis via Reactive Oxygen Species in the T-47D Breast Cancer Cell Line.

Zahra Shahsavari1, Fatemeh Karami-Tehrani, Siamak Salami.   

Abstract

Breast cancer, the most common cancer in the women, is the leading cause of death. Necrotic signaling pathways will enable targeted therapeutic agents to eliminate apoptosis-resistant cancer cells. In the present study, the effect of shikonin on the induction of cell necroptosis or apoptosis was evaluated using the T-47D breast cancer cell line. The cell death modes, caspase-3 and 8 activities and the levels of reactive oxygen species (ROS) were assessed. Cell death mainly occurred through necroptosis. In the presence of Nec-1, caspase-3 mediated apoptosis was apparent in the shikonin treated cells. Shikonin stimulates ROS generation in the mitochondria of T-47D cells, which causes necroptosis or apoptosis. Induction of necroptosis, as a backup-programmed cell death pathway via ROS stimulation, offers a new strategy for the treatment of breast cancer.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26514521     DOI: 10.7314/apjcp.2015.16.16.7261

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  15 in total

1.  Shikonin induces glioma cell necroptosis in vitro by ROS overproduction and promoting RIP1/RIP3 necrosome formation.

Authors:  Bin Lu; Xu Gong; Zong-Qi Wang; Ye Ding; Chen Wang; Tian-Fei Luo; Mei-Hua Piao; Fan-Kai Meng; Guang-Fan Chi; Yi-Nan Luo; Peng-Fei Ge
Journal:  Acta Pharmacol Sin       Date:  2017-08-17       Impact factor: 6.150

2.  Shikonin induces necroptosis by reactive oxygen species activation in nasopharyngeal carcinoma cell line CNE-2Z.

Authors:  Zixuan Zhang; Zhirui Zhang; Qixiang Li; Hao Jiao; Dianlong Chong; Xiaojin Sun; Pei Zhang; Qiang Huo; Hao Liu
Journal:  J Bioenerg Biomembr       Date:  2017-05-25       Impact factor: 2.945

Review 3.  Complex Pathologic Roles of RIPK1 and RIPK3: Moving Beyond Necroptosis.

Authors:  Kelby W Wegner; Danish Saleh; Alexei Degterev
Journal:  Trends Pharmacol Sci       Date:  2017-01-23       Impact factor: 14.819

Review 4.  RIPK3 signaling and its role in the pathogenesis of cancers.

Authors:  Shanhui Liu; Kanak Joshi; Mitchell F Denning; Jiwang Zhang
Journal:  Cell Mol Life Sci       Date:  2021-10-15       Impact factor: 9.207

5.  Cytotoxic effect of silica nanoparticles against hepatocellular carcinoma cells through necroptosis induction.

Authors:  Yuexiang Niu; Engong Tang; Qingan Zhang
Journal:  Toxicol Res (Camb)       Date:  2019-11-20       Impact factor: 3.524

6.  Molecular mechanism of shikonin inhibiting tumor growth and potential application in cancer treatment.

Authors:  Qiang Wang; Jing Wang; Jiayou Wang; Xiaoli Ju; Heng Zhang
Journal:  Toxicol Res (Camb)       Date:  2021-11-26       Impact factor: 3.524

7.  Shikonin induces ROS-based mitochondria-mediated apoptosis in colon cancer.

Authors:  Wenquan Liang; Jianxin Cui; Kecheng Zhang; Hongqing Xi; Aizhen Cai; Jiyang Li; Yunhe Gao; Chong Hu; Yi Liu; Yixun Lu; Ning Wang; Xiaosong Wu; Bo Wei; Lin Chen
Journal:  Oncotarget       Date:  2017-11-17

8.  Pharmacological Inhibition of Necroptosis Promotes Human Breast Cancer Cell Proliferation and Metastasis.

Authors:  Feng Shen; Xiangou Pan; Min Li; Ying Jiang; Jian He; Yixing Chen
Journal:  Onco Targets Ther       Date:  2020-04-16       Impact factor: 4.147

Review 9.  Necroptosis in tumorigenesis, activation of anti-tumor immunity, and cancer therapy.

Authors:  Mao-Bin Meng; Huan-Huan Wang; Yao-Li Cui; Zhi-Qiang Wu; Yang-Yang Shi; Nicholas G Zaorsky; Lei Deng; Zhi-Yong Yuan; You Lu; Ping Wang
Journal:  Oncotarget       Date:  2016-08-30

10.  Anticancer Efficacy of Targeted Shikonin Liposomes Modified with RGD in Breast Cancer Cells.

Authors:  Xianchun Wen; Jiping Li; Defu Cai; Liling Yue; Qi Wang; Li Zhou; Li Fan; Jianwen Sun; Yonghui Wu
Journal:  Molecules       Date:  2018-01-29       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.